Substrate
health

Study Finds Traded Mammals 50 Percent More Likely to Share Pathogens with Humans

A study published in Science analyzed over 2,000 traded mammal species and found that 41 percent share at least one pathogen with humans, compared to 6.4 percent of non-traded species. Traded mammals are 1.5 times more likely to share pathogens. The research highlights risks from the wildlife trade, including legal and illegal activities.

The Telegraph
1 source·Apr 9, 6:00 PM(34 days ago)·2m read
Study Finds Traded Mammals 50 Percent More Likely to Share Pathogens with HumansSubstrate placeholder — needs review
Audio version
Tap play to generate a narrated version.

A study published in the journal Science on Thursday examined the spillover risks from the wildlife trade. Researchers analyzed data from over 2,000 traded mammal species, comparing it to international trade records and pathogen databases. The analysis covered both legal and illegal aspects of the trade.

The study determined that 41 percent of traded mammals share at least one pathogen with humans. 4 percent of mammal species not involved in breeding, transportation, buying, or selling share such pathogens. 5 times more likely to share pathogens with humans than non-traded mammals.

Jérôme Gippet, a postdoctoral researcher at the University of Fribourg and lead author of the paper, commented on the results.

It was surprising to find such a clear signal between this trade and the number of pathogens shared between [mammals and] humans.

Dr. Jérôme Gippet (The Telegraph)

Gippet added that the findings indicate the wildlife trade promotes pathogen transmission from animals to humans. The study connects the wildlife trade to pathogen emergence, noting conditions in the trade such as cramped and unsanitary environments for animals.

Past outbreaks provide context for these risks. The SARS outbreak in 2002-2003 was traced to the civet cat trade, and the Ebola outbreak in West Africa from 2014 was linked to bushmeat consumption or contact.

A World Health Organization committee concluded last year that the weight of available evidence suggests COVID-19 emerged from a zoonotic spillover, though it has not excluded a laboratory leak. Scientists not involved in the study described it as a definitive quantification of spillover risks from the wildlife trade.

Prof. Edward Holmes, an evolutionary biologist and virologist at the University of Sydney, noted the scale of the analysis as a key factor in its significance. The wildlife trade affects global health by facilitating pathogen transmission. Stakeholders include traders, consumers, and public health officials.

Future steps may involve policy measures to regulate the trade and reduce risks, though the study does not specify recommendations.

Key Facts

41 percent
traded mammals share pathogens with humans
6.4 percent
non-traded mammals share pathogens with humans
1.5 times
higher likelihood for traded mammals
Over 2,000 species
analyzed in the study

Story Timeline

4 events
  1. Thursday

    Study published in Science journal analyzing traded mammal pathogens.

    1 sourceThe Telegraph
  2. Last year

    WHO committee concluded COVID-19 likely from zoonotic spillover.

    1 sourceThe Telegraph
  3. 2014

    Ebola outbreak in West Africa linked to bushmeat contact.

    1 sourceThe Telegraph
  4. 2002-2003

    SARS outbreak traced to civet cat trade.

    1 sourceThe Telegraph

Potential Impact

  1. 01

    Increased awareness may lead to stricter wildlife trade regulations.

  2. 02

    Public health agencies could prioritize monitoring of traded animals.

  3. 03

    Zoonotic disease outbreaks could rise without trade interventions.

  4. 04

    Researchers may conduct further studies on specific trade routes.

Transparency Panel

Sources cross-referenced1
Confidence score70%
Synthesized bySubstrate AI
Word count336 words
PublishedApr 9, 2026, 6:00 PM
Bias signals removed3 across 2 outlets
Signal Breakdown
Amplifying 1Loaded 1Editorializing 1

Related Stories

Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reformsthehindu.com
health7 hrs agoDeveloping

Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reforms

The administration is moving quickly to find a successor after FDA Commissioner Marty Makary resigned on Tuesday. Officials want the next leader to rebuild trust with agency staff, emphasize food policy and continue drug-approval reforms. The search is expected to take several we…

Stat
1 source
Trump Sides With Tobacco Industry in Vape Disputerediff.com
health11 hrs agoDeveloping

Trump Sides With Tobacco Industry in Vape Dispute

President Trump intervened in a regulatory dispute over vaping products, supporting tobacco companies against a position held by his own administration's officials. The Food and Drug Administration commissioner resigned in protest following the decision. The New York Times report…

The New York Times
1 source
NYU Langone Receives Federal Grand Jury Subpoena on Gender-Affirming Care for MinorsStat
health11 hrs agoFraming65Framing risk65/100Rewrite inherits heavy consensus framing from sources by centering the subpoena as an aggressive Trump-era escalation while burying the substantive event of potential fraud in pediatric gender care.Click to jump to full framing analysis

NYU Langone Receives Federal Grand Jury Subpoena on Gender-Affirming Care for Minors

NYU Langone Health disclosed last week that it received a grand jury subpoena from the U.S. Attorney’s Office in the Northern District of Texas seeking records on minors who received gender-affirming care from 2020 to 2026. The request marks a shift from prior administrative subp…

Stat
Hot Air
2 sources